Abstract
Background
As shown earlier by the authors via Western blot analysis, open (OS) but not laparoscopic surgery (LS) induces a qualitative decrease in plasma insulin-like growth factor–binding protein 3 (IGFBP-3) levels on postoperative day 1 (POD 1). Intact IGFBP-3 has tumor suppressive effects, but its degradation products do not. Enzyme linked immunoassay (ELISA) inevitably measures both. In this study, using a novel combined Western blot and ELISA analysis method, precise plasma levels of intact IGFBP-3 on POD2 after open and closed colorectal cancer resection (stage I–III) were determined.
Methods
This study included 15 OS patients with a mean incision length of 26.7 ± 15.5 cm and 16 LS patients with a mean incision length of 5.3 ± 3.1 cm. Intact IGFBP-3 levels were determined via ELISA and Western blot analysis in plasma collected preoperatively and postoperatively.
Results
In the OS patients, the mean preoperative concentration of intact 43–45 kDa IGFBP-3 protein was 1920 ± 1430 ng/ml. It decreased dramatically on POD2 to 355 ± 545 ng/ml (p < 0.005). In the LS group, no significant difference was noted between the preoperative level (1305 ± 807 ng/ml) and the POD2 level (922 + 714 ng/ml).
Conclusions
Open cancer resection, unlike its minimally invasive alternative, induces a dramatic decrease in concentration of intact IGFBP-3, which may have important implications with regard to colon cancer recurrence.
Similar content being viewed by others
References
RC Baxter JL Martin MI Tyler MR Howden (1986) ArticleTitleGrowth hormone–dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins Biochem Biophys Res Commun 139 1256–1261 Occurrence Handle1:CAS:528:DyaL28XlvVKiu7w%3D Occurrence Handle2945561
BA Booth M Boes RS Bar (1996) ArticleTitleIGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments Am J Physiol 271 IssueID3 Pt 1 E465–E470 Occurrence Handle1:CAS:528:DyaK28XmtFajtrY%3D Occurrence Handle8843739
BA Booth M Boes BL Dake KL Knudtson RS Bar (2002) ArticleTitleIGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis Am J Physiol Endocrinol Metab 282 E52–E58
BJ Boyle XY Zhao P Cohen D Feldman (2001) ArticleTitleInsulin-like growth factor binding protein-3 mediates 1 alpha, 25dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1 J Urol 165 1319–1324 Occurrence Handle10.1097/00005392-200104000-00077 Occurrence Handle1:CAS:528:DC%2BD3MXisVygs7g%3D Occurrence Handle11257709
ML Cubbage A Suwanichkul DR Powell (1990) ArticleTitleInsulin-like growth factor binding protein-3: organization of the human chromosomal gene and demonstration of promoter activity J Biol Chem 265 12642–12649 Occurrence Handle1:CAS:528:DyaK3cXmtVGrtr4%3D Occurrence Handle1695633
F Benedetti ParticleDe C Meazza M Oliveri P Pignatti M Vivarelli T Alonzi E Fattori S Garrone A Barreca A Martini (2001) ArticleTitleEffect of IL-6 on IGF-binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis Endocrinology 142 4818–4826 Occurrence Handle10.1210/en.142.11.4818 Occurrence Handle11606449
JL Fowlkes JJ Enghild K Suzuki H Nagase (1994) ArticleTitleMatrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures J Biol Chem 269 25742–25746 Occurrence Handle1:CAS:528:DyaK2cXlvFKksbo%3D Occurrence Handle7523391
ZP Gill CM Perks PV Newcomb JM Holly (1997) ArticleTitleInsulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner J Biol Chem 272 25602–25607 Occurrence Handle10.1074/jbc.272.41.25602 Occurrence Handle1:CAS:528:DyaK2sXms1Gis78%3D Occurrence Handle9325280
H Gronbek T Thogersen J Frystyk H Vilstrup A Flyvbjerg JF Dahlerup (2002) ArticleTitleLow free and total insulin-like growth factor 1 (IGF-I) and IGF-binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment Am J Gastroenterol 97 673–678 Occurrence Handle1:STN:280:DC%2BD387ovFGlsg%3D%3D Occurrence Handle11922563
J Hong G Zhang F Dong MM Rechler (2002) ArticleTitleInsulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells J Biol Chem 277 10489–10497 Occurrence Handle10.1074/jbc.M109604200 Occurrence Handle1:CAS:528:DC%2BD38XisVyksrY%3D Occurrence Handle11784719
I Kirman V Cekic N Poltaratskaia Z Asi M Bessler EH Huang KA Forde RL Whelan (2002) ArticleTitlePlasma from patients undergoing major open surgery stimulates in vitro, tumor growth: lower insulin-like growth factor-binding protein-3 levels may, in part, account for this change Surgery 132 186–192 Occurrence Handle10.1067/msy.2002.125308 Occurrence Handle12219010
I Kirman N Poltaratskaia V Cekic K Forde P Ansari C Boulay RL Whelan (2004) ArticleTitleDepletion of circulating insulin-like growth factor-binding protein-3 following open surgery is associated with high IL-6 levels Dis Colon Rectum 47 911–917 Occurrence Handle10.1007/s10350-004-0512-4 Occurrence Handle15085435
HY Lee KH Chun B Liu SA Wiehle RJ Cristiano WK Hong P Cohen JM Kurie (2002) ArticleTitleInsulin-like growth factor-binding protein-3 inhibits the growth of non–Small cell lung cancer Cancer Res 62 3530–3537 Occurrence Handle1:CAS:528:DC%2BD38XkslWqtrc%3D Occurrence Handle12068000
L Li H Yu F Schumacher G Casey JS Witte (2003) ArticleTitleRelation of serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 to risk of prostate cancer (United States) Cancer Causes Control 14 721–726 Occurrence Handle10.1023/A:1026383824791 Occurrence Handle14674736
J Ma MN Pollak E Giovannucci JM Chan Y Tao CH Hennekens MJ Stampfer (1999) ArticleTitleProspective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF-I) and IGF-binding protein-3 J Natl Cancer Inst 91 620–625
O Manousos J Souglakos C Bosetti A Tzonou V Chatzidakis D Trichopoulos HO Adami C Mantzoros (1999) ArticleTitleIGF-I and IGF-II in relation to colorectal cancer Int J Cancer 83 15–17 Occurrence Handle10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y Occurrence Handle1:CAS:528:DyaK1MXlvF2nsL4%3D Occurrence Handle10449601
JL Martin RC Baxter (1986) ArticleTitleInsulin-like growth factor-binding protein from human plasma: Purification and characterization J Biol Chem 261 8754–8760 Occurrence Handle1:CAS:528:DyaL28XksFKmu7g%3D Occurrence Handle3722172
A Matsuyama N Sakai M Ishigami H Hiraoka S Kashine A Hirata T Nakamura S Yamashita Y Matsuzawa (2003) ArticleTitleMatrix metalloproteinases as novel disease markers in Takayasu arteritis Circulation 108 1469–1473
S Miyamoto K Yano S Sugimoto G Ishii T Hasebe Y Endoh K Kodama M Goya T Chiba A Ochiai (2004) ArticleTitleMatrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor-binding protein-3 Cancer Res 64 665–671 Occurrence Handle1:CAS:528:DC%2BD2cXmsVahug%3D%3D Occurrence Handle14744783
AG Renehan JE Painter WS Atkin CS Potten SM Shalet ST O’Dwyer (2001) ArticleTitleHigh-risk colorectal adenomas and serum insulin-like growth factors Br J Surg 88 107–113
AG Renehan JE Painter D O’Halloran WS Atkin CS Potten ST O’Dwyer SM Shalet (2000) ArticleTitleCirculating insulin-like growth factor 2 and colorectal adenomas J Clin Endocrinol Metab 85 3402–3408 Occurrence Handle10.1210/jc.85.9.3402 Occurrence Handle1:CAS:528:DC%2BD3cXmsVKqtr0%3D Occurrence Handle10999841
I Tchetverikov LR Lard J DeGroot N Verzijl JM TeKoppele FC Breedveld TW Huizinga R Hanemaaijer (2003) ArticleTitleMatrix metalloproteinases-3, 8, 9 as markers of disease activity and joint damage progression in early rheumatoid arthritis Ann Rheum Dis 62 1094–1099 Occurrence Handle10.1136/ard.62.11.1094 Occurrence Handle1:CAS:528:DC%2BD3sXpsVSksL0%3D Occurrence Handle14583574
B Valentinis A Bhala T DeAngelis R Baserga P Cohen (1995) ArticleTitleThe human insulin-like growth factor (IGF)-binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene Mol Endocrinol 9 361–367 Occurrence Handle10.1210/me.9.3.361 Occurrence Handle1:CAS:528:DyaK2MXktlKntr4%3D Occurrence Handle7539889
H Zhao HB Grossman MR Spitz SP Lerner K Zhang X Wu (2003) ArticleTitlePlasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk J Urol 169 714–717 Occurrence Handle10.1097/00005392-200302000-00071 Occurrence Handle1:CAS:528:DC%2BD3sXmtl2ktQ%3D%3D Occurrence Handle12544349
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kirman, I., Cekic, V., Poltoratskaia, N. et al. Open surgery induces a dramatic decrease in circulating intact IGFBP-3 in patients with colorectal cancer not seen with laparoscopic surgery. Surg Endosc 19, 55–59 (2005). https://doi.org/10.1007/s00464-004-8906-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-004-8906-x